Finerenone: Reducing Progressive Kidney Dysfunction and Secondary Cardiovascular Complications in Patients With Chronic Kidney Disease Associated With Type 2 Diabetes

被引：0
|
作者：
Beacom, Robin E. [1 ]
Blankenship, James K. [2 ]
Harrington, Deedra H. [2 ]
机构：
[1] Univ Louisiana Lafayette, Coll Nursing & Hlth Sci, Lafayette, LA 70504 USA
[2] Univ Louisiana, Coll Nursing & Hlth Sci, Lafayette, LA USA
来源：
JNP- THE JOURNAL FOR NURSE PRACTITIONERS | 2022年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.nurpra.2022.04.009
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
[No abstract available]
引用
收藏
页码：800 / 801
页数：2
相关论文
共 50 条
  • [31] The cardiovascular outcomes of finerenone in patients with chronic kidney disease and type 2 diabetes: A meta-analysis of randomized clinical trials
    Abdelazeem, Basel
    Elbadawy, Merihan A.
    Awad, Ahmed K.
    Kheiri, Babikir
    Kunadi, Arvind
    INTRACTABLE & RARE DISEASES RESEARCH, 2022, 11 (01) : 31 - 33
  • [32] Medical Costs for Managing Chronic Kidney Disease and Related Complications in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Betts, Keith A.
    Song, Jinlin
    Faust, Elizabeth
    Yang, Karen
    Du, Yuxian
    Kong, Sheldon X.
    Singh, Rakesh
    AMERICAN JOURNAL OF MANAGED CARE, 2021, 27 (20): : S369 - S374
  • [33] Modifying chronic kidney disease progression with the mineralocorticoid receptor antagonist finerenone in patients with type 2 diabetes
    DeFronzo, Ralph A.
    Bakris, George L.
    DIABETES OBESITY & METABOLISM, 2022, 24 (07): : 1197 - 1205
  • [34] Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone
    Agarwal, Rajiv
    Anker, Stefan D.
    Bakris, George
    Filippatos, Gerasimos
    Pitt, Bertram
    Rossing, Peter
    Ruilope, Luis
    Gebel, Martin
    Kolkhof, Peter
    Nowack, Christina
    Joseph, Amer
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (06) : 1014 - 1023
  • [35] Efficacy and safety of finerenone by age and sex subgroups in patients with chronic kidney disease and type 2 diabetes
    Bansal, S.
    Anker, S.
    Bakris, G.
    Filippatos, G.
    Rossing, P.
    Ruilope, L.
    Birne, R.
    Canziani, M.
    Farjat, A.
    Brinker, M.
    Pitt, B.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [36] Hypokalaemia in patients with type 2 diabetes and chronic kidney disease: the effect of finerenone-a FIDELITY analysis
    Pitt, Bertram
    Agarwal, Rajiv
    Anker, Stefan D.
    Rossing, Peter
    Ruilope, Luis
    Herzog, Charles A.
    Greenberg, Barry
    Pecoits-Filho, Roberto
    Lambelet, Marc
    Lawatscheck, Robert
    Scalise, Andrea
    Filippatos, Gerasimos
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 11 (01) : 10 - 19
  • [37] Effect of finerenone on the incidence of hypokalemia in patients with type 2 diabetes and chronic kidney disease: A FIDELITY analysis
    Pitt, B.
    Agarwal, R.
    Anker, S.
    Bakris, G.
    Rossing, P.
    Ruilope, L.
    Herzog, C.
    Greenberg, B.
    Pecoits-Filho, R.
    Zannad, F.
    Lambelet, M.
    Lawatscheck, R.
    Scalise, A.
    Filippatos, G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 415 - 415
  • [38] Long-term cardiorenal efficacy of finerenone in patients with chronic kidney disease and type 2 diabetes
    Qiu, Mei
    Zhao, Li-Min
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (10) : 11239 - 11241
  • [39] Single institution prescribing pattern of finerenone in patients with type 2 diabetes and/or chronic kidney disease in the USA
    Zhang, Rong M.
    CLINICAL KIDNEY JOURNAL, 2023, 16 (09) : 1538 - 1539
  • [40] Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes
    Agarwal, Rajiv
    Ruilope, Luis M.
    Ruiz-Hurtado, Gema
    Haller, Hermann
    Schmieder, Roland E.
    Anker, Stefan D.
    Filippatos, Gerasimos
    Pitt, Bertram
    Rossing, Peter
    Lambelet, Marc
    Nowack, Christina
    Kolkhof, Peter
    Joseph, Amer
    Bakris, George L.
    JOURNAL OF HYPERTENSION, 2023, 41 (02) : 295 - 302
12345